245620 — Eone Diagnomics Genome Center Co Cashflow Statement
0.000.00%
Last trade - 00:00Consumer DefensivesSpeculativeMicro Cap
Annual cashflow statement for Eone Diagnomics Genome Center Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | R2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | ARS | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -20,229 | -29,789 | -33,027 | -95,241 | 28,242 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 7,022 | 21,013 | 25,164 | 86,279 | -32,282 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 5,886 | -8,292 | -12,431 | 10,754 | 6,949 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -1,730 | -10,892 | -14,025 | 6,691 | 3,496 |
| Capital Expenditures | -13,786 | -39,409 | -6,083 | -1,843 | -27.9 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -45,225 | 2,961 | 10,093 | 863 | -3,761 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Sale of Intangible Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -59,011 | -36,448 | 4,011 | -980 | -3,788 |
| Financing Cash Flow Items | -156 | -2,378 | -12.1 | 23.4 | 4,200 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 27,467 | 24,081 | 14,616 | -5,701 | 4,166 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -33,067 | -22,851 | 4,749 | 73.8 | 3,883 |